Brian Andrew Van Tine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial”.

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

The Lancet(2024)10.1016/s0140-6736(24)01812-9

N/A

1.4DataRank · unranked

84 citations

Karla V. Ballman, Angela Hong, Scott M. Schuetze, Andrew J. Wagner, Varun Monga +23 more

A randomized phase II study of MLN0128 (M) versus pazopanib (P) in patients (pt) with advanced sarcoma (Alliance A091304).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11562

N/A

0DataRank · unranked

7 citations

Michelle R. Mahoney, Fabrizio Remotti, Ardaman Shergill, Mark A. Dickson, Richard F. Riedel +10 more

Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma

Cell Reports(2021)10.1016/j.celrep.2020.108678

N/A

0DataRank · unranked

49 citations

Katharine E. Caldwell, Charles R. Schutt, Caitlyn B. Brashears, Bethany C. Prudner, William Ehrhardt +11 more

Phase II study of atezolizumab in advanced alveolar soft part sarcoma (ASPS).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11519

N/A

0DataRank · unranked

50 citations

Geraldine O’Sullivan Coyne, Nancy Moore, Elad Sharon, Naoko Takebe, Kristin Fino +15 more

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11503

N/A

0DataRank · unranked

10 citations

Karla V. Ballman, Kristen Ganjoo, Elizabeth J. Davis, Jeffrey A. Morgan, Gabriel Tinoco +15 more

A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11511

N/A

0DataRank · unranked

50 citations

Michelle R. Mahoney, Suzanne George, Cristina R. Antonescu, David A. Liebner, Brian Andrew Van Tine +6 more

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

Cancer Cell(2022)10.1016/j.ccell.2022.12.001

N/A

0DataRank · unranked

216 citations

T. Mamie Lih, Saravana M. Dhanasekaran, Rahul Mannan, Lijun Chen, Marcin Cieślik +95 more

Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism

Cell Reports Medicine(2022)10.1016/j.xcrm.2021.100498

N/A

0DataRank · unranked

19 citations

Cassandra B. Higgins, Brian Andrew Van Tine, John S. Bomalaski, Brian J. DeBosch, Yiming Zhang

NRG-DT001 phase Ib trial of neoadjuvant navtemadlin (previously AMG232 and KRT232) concurrent with preoperative radiotherapy in wild-type p53 soft tissue sarcoma of the extremity and body wall.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11521

N/A

0DataRank · unranked

2 citations

Pedro A. Torres‐Saavedra, Brian Andrew Van Tine, David G. Kirsch, Michelle A. Rudek, Paul E. Wakely +13 more

Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11584

N/A

0DataRank · unranked

2 citations

Sumithra J. Mandrekar, Jacob B. Allred, Stephanie Berg, Martee L. Hensley, Brian Andrew Van Tine +4 more

Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11508

N/A

0DataRank · unranked

9 citations

Angela C. Hirbe, Jingqin Luo, Peter John Oppelt, Mia C. Weiss, Vanessa Eulo +14 more